VOLUME 62   2001   SUPPLEMENT 27

ARTICLES

3 Introduction: Metabolic Disturbances Associated With Antipsychotic Use. John W. Newcomer
[PDF]

5 Diagnosis, Classification, and Pathogenesis of Diabetes Mellitus. Harold E. Lebovitz
[Abstract] [PDF]

10 Clinical Experience With Insulin Resistance, Diabetic Ketoacidosis, and Type 2 Diabetes Mellitus in Patients Treated With Atypical Antipsychotic Agents. David C. Henderson
[Abstract] [PDF]

15 Hyperglycemia and Antipsychotic Medications. Dan W. Haupt and John W. Newcomer
[Abstract] [PDF]

27 Effects of Atypical Antipsychotics on Weight and Serum Lipid Levels. Jonathan M. Meyer
[Abstract] [PDF]

35 Putting Metabolic Side Effects Into Perspective: Risks Versus Benefits of Atypical Antipsychotics. Herbert Y. Meltzer
[Abstract] [PDF]

40 Concluding Discussion: Metabolic Disturbances Associated With Antipsychotic Use.
[PDF]

CME Section

42 Instructions and Posttest.
[PDF]

44 Registration Form and Evaluation.
[PDF]